Purpose of review In this review, we discuss recent advances into delineating the dual role of intestinal phagocytes in health and during intestinal disease. We further discuss the key role of gut-resident macrophages in recognition of bacterial and fungal microbiota in the gut.
INTRODUCTION

The yin and yang of intestinal macrophages
Due to their functional role and location in close proximity to the intestinal epithelium mononuclear phagocytes have been historically considered as both 'sensors' and 'responders' to the intestinal environment. Macrophages in the gastrointestinal tract of both human and mouse share a similar distribution, a high threshold to activation upon stimuli, and the expression of phagocytic and pattern recognition receptors. Yet, they are characterized by different combination of surface markers including CD11b, the fractalkine receptor CX3CR1, F4/80 and CD11c [1,2,3 && ]. Mononuclear phagocytes expressing the CX3CR1 and displaying a macrophage phenotype, have been shown to play a key role in the uptake of food antigen, an in the sampling of bacterial and fungal antigens from the intestinal lumen [3 && , [4] [5] [6] [7] . The majority of these intestinal lamina propria macrophages differentiate from CCR2 þ CX3CR1 int Ly6C hi monocytes and are constantly replenished during the steady state [1] ( Fig. 1) . Their ability to sense the intestinal environment during steady state and the innate capacity to overdrive inflammatory immunity during intestinal disease put intestinal macrophages at the crossroad between protective immunity and inflammation. Understanding the mechanisms controlling this dual function holds major promise for improving
Role on gut-resident macrophages in the maintenance of intestinal immune homeostasis
Consistent with their role in controlling immune responses to microbiota, diet and other environmental cues, mononuclear phagocytes have been shown to play a role in restriction of intestinal inflammation through direct control of the microbiota or through the release of local anti-inflammatory molecules (Fig. 1) . Studies in children with very early onset IBD have underlined the importance of IL-10 in preventing intestinal inflammation with macrophages being key responders to this cytokine [8] [9] [10] . Recent study further defined a subset of interleukin 10 (IL-10) producing CD11c À mononuclear phagocytes in the human colon [11 & ]. These tolerogenic CD11c À phagocytes originated from monocytes following mucosal conditioning in the intestine and were decreased in inflamed colons of IBD patients [11 & ,12] . In contrast to the colon, IL-10 producing macrophages are less common in the small intestine. Transcriptional and functional profiling of macrophages in duodenal transplants defined four distinct populations of these cells, albeit none of them produced IL-10 [13] . Although the response to IL-10 rather than its production seems to be important for the maintenance of tolerogenic properties of macrophages [10] , these findings hint at a compartmentalization of IL-10 producing macrophages in the human gut that correlates with dietary factors and specific microbial distribution.
Other molecules, such as transforming growth factor beta (TGF-b) and retinoic acid (RA), are important for the anti-inflammatory properties of
KEY POINTS
At steady state, gut-resident macrophages are required for the establishment of an immunoregulatory response.
In IBD patients, intestinal inflammation affects the maturation of infiltrating monocytes into tolerogenic macrophages and results in the accumulation of proinflammatory monocytes.
Gut-resident macrophages are required to control intestinal fungi and bacteria.
Defects in CX3CR1
þ mononuclear phagocyte function worsens gut intestinal inflammation.
Loss of function mutation in CX3CR1 affects the induction of humoral responses against intestinal fungi in Crohn's disease patients. intestinal macrophages (Fig. 1) . However, major differences between human and mouse macrophages have been described in this regard. Although human-gut-resident macrophages are able to produce retinoic acid, in mice this property is restricted to conventional dendritic cells [14] [15] [16] [17] . Furthermore, retinoic acid might have different impact on macrophages during the steady state and during inflammation. Indeed, retinoic acid production by infiltrating monocytes and macrophages has been reported in patients with Crohn's disease, whereas blockade of retinoic acid receptor signaling reduced tumor necrosis factor alpha (TNFa) production by these cells in vitro [17] . Similarly, in human-gutresident macrophages TGF-b might play a more central role in inducing hyporesponsiveness of those cells to microbial products than in mice [2] .
Numerous reports have established an important role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the control of monocyte dependent mucosal homeostasis in IBD. GM-CSF enhances both antimicrobial and immunoregulatory properties of intestinal monocytes and macrophages [18] . Loss of GM-CSF signaling through either production of GM-CSF autoantibodies [19] , decreased cell surface abundance of the GM-CSF receptor alpha chain subunit CD116 [20] or frameshift mutations leading to reduced GM-CSF dependent signal transducer and activator of transcription 5 (STAT5) activation [21] have been associated with increased risk for Crohn's disease.
In addition to secretory molecules, the peroxisome proliferator-activated receptor gamma (PPARg) axis was recently shown to play critical roles in the polarization of tolerogenic intestinal macrophage. Inhibition of the mammalian target of rapamycin or loss of semaphorin 6D, both leading to loss of PPARg signaling, caused a metabolic reprograming and promoted an inflammatory phenotype in CX3CR1 þ macrophages thus contributing to development of colitis [22] .
Gut-resident macrophages and intestinal inflammation
During inflammation in both mice and humans, mononuclear phagocytes expand in the intestinal lamina propria [1, 2, 17, 23] . Inflammation can also profoundly affect the differentiation of monocytes to fully mature and functional macrophages (Fig. 1) . CD11c high CCR2 þ CX3CR1 þ monocytes that infiltrated in the colonic intestinal mucosa of IBD patients in a CCR2-dependent manner did not differentiate fully to macrophages and produced the proinflammatory cytokine IL-1b [11 & ]. Macrophages isolated from patients with Crohn''s disease produced higher levels of IL-1b upon stimulation, which correlated with decreased levels of inositol polyphosphate 5 0 -phosphatase D (INPP5D, also known as SHIP) [24] . Consistently, macrophages from SHIP-deficient mice showed increased Il1b levels, which contributed to spontaneous ileal inflammation [24] . Increased monocyte infiltration and production of large amounts of proinflammatory mediators including TNFa, IL-1, IL-23, nitric oxide by monocytes and macrophages is a key characteristic of IBD [1, 2, 16, 17, 23, 25] (Fig. 1) .
In addition to the proinflammatory cytokine IL-1, IL-23 produced by CD11c þ mononuclear phagocytes (MNPs) was also identified as a strong inflammatory mediator to trigger intestinal inflammation in Helicobacter hepaticus-induced IL-10R deficiency colitis model [26 && ,27] . Cyclic induction of IL-23 production by CX3CR1
þ MNPs predisposed mice to diet-induced colitis [28] . This, together with recent clinical study conducted in Crohn's disease patients treated with ustekinumab (p40 subunit blockade, targeting both IL-12 and IL-23) [29] , suggest that IL-12/IL-23 blockade might act by targeting monocytes and macrophages to suppress intestinal inflammation in IBD.
Bacterial interactions with mononuclear phagocytes in health and during intestinal disease
Gut microbiota plays an important role in maintenance of the tolerogenic function of intestinal macrophages (Fig. 1) . Bacterial dysbiosis is strongly associated with intestinal inflammation and IBD [30] [31] [32] . Microbial sensing by macrophages promotes GM-CSF production by type 3 innate lymphoid (ILC3) cells [33] . Disruption of this regulatory loop led to reduced regulatory T cell (Treg) numbers and increased intestinal inflammation [33] . Similarly, the interaction among microbiota, macrophages and ILC3 has been shown to control IL-22 release and play a role in intestinal epithelial cell healing [34] .
Intestinal epithelium-adhering bacteria can interact with CX3CR1 þ MNPs to modulate the immune balance in health and diseases. Segmented filamentous bacteria interaction with the gut epithelium induced Th17 responses through CX3CR1 þ MNPs [35,36 & ]. Expansion of adherent-invasive Escherichia coli (AIEC) has been reported in the ileal mucosa during active Crohn's disease [37, 38] . AIEC was capable to induce IL-10 production by CX3CR1 þ MNPs and suppressed Th17 immune responses [36 & ,38]. In the absence of IL-10 signaling, AIEC induced Th17 immune responses and aggravated intestinal disease in IL-10 knockout mice, but not in wild-type mice [38] . Similarly, loss of IL-10 signaling resulted in severe colitis in mice upon dietdriven expansion of pathobionts such as Bilophila wadsworthia [39] . The role of CX3CR1 þ MNPs in the maintenance of noninflammatory state is further emphasized by depletion experiments leading to the expansion of Th1 and Th17 cells in mice colonized with intestinal epithelium-adhering bacteria [36 & ]. Tolerogenic responses seem to be further controlled by the presence of healthy commensal microbiota, as antibiotic-induced dysbiosis abrogated the tolerogenic effect of CX3CR1
þ MNPs on Treg differentiation [36 & ]. Recently, oral cavity-derived Klebsiella species have been shown to colonize the intestine of IBD patients [40] . Intestinal colonization with patientderived Klebsiella spp. has been shown to induce severe colitis upon IL-10 deficiency via the induction of Th1 proinflammatory immune response [40] . However, Klebsiella failed to exacerbate intestinal inflammation in wild-type, indicating that IL-10 is required to restrain the Klebsiella-induced pathogenic Th1 immune response. Although it has been suggested that intestinal phagocytes (CD11b
þ dendritic cells) can sense Klebsiella spp. and induce Th1 cells polarization, whether intestinal phagocytes, such as CX3CR1 þ MNPs are involved to control immune homeostasis balance when ectopically bacteria colonize the gut of healthy individual remains to be investigated. Altogether, these studies suggest that CX3CR1
þ MNPs are crucial to regulating the balance between effector T cells and Tregs under immune homeostatic condition to limit intestinal disease development.
Fungal interactions with mononuclear phagocytes in health and during intestinal disease
Two major Phyla, Ascomycota and Basidiomycota, dominate the intestinal mycobiota in human and in mice. Among the Ascomycota, Candida and Saccharomyces are among the most prevalent and abundant genera in the human intestine. Intestinal fungi have been shown to affect the intestinal niche both directly or through the modulation of the intestinal microbiota [3 && , 41,42 & ,43] . Monocolonization of germ-free mice with Candida albicans or Saccharomyces cerevisiae promotes the establishment of intestinal homeostasis. Importantly, both species exert a striking protective effect against mucosal injury in a model in which bacteria are depleted with a combination of broad-spectrum antibiotics [44 & ]. Targeting the healthy fungal community can also lead to undesired consequences. We have shown that in specific-pathogen-free (SPF) mice, perturbation of the fungal microbiota using antifungal drugs has a detrimental impact on the development of intestinal inflammation [41] . These studies suggest that intestinal fungi are not intrinsically detrimental. Rather, fungal communities contribute to the maintenance of intestinal homeostasis in healthy hosts but can worsen the disease outcome in conditions permissive of the overgrowth of potentially pathogenic fungal species.
Several factors including diet, oral hygiene or medications can influence the composition of the mycobiota without altering intestinal homeostasis [45] . More dramatic perturbations of the fungal communities have been observed in IBD patients and have been associated with the disruption of the epithelial barrier and the shift to a proinflammatory environment that could favor the development of intestinal inflammation. In particular, an increased abundance of Candida spp. is associated with both experimentally induced intestinal inflammation and IBD [3
&&
, [46] [47] [48] [49] [50] . Intestinal colonization with S. cerevisiae and Candida glabrata has been shown to exacerbate the outcome of chemically induced colitis in wild-type SPF mice [42 & ,43] . Importantly, the detrimental effect of fungal species has been demonstrated in models where intestinal homeostasis was strongly compromised or where the fungal load was greatly increased. In the clinics, these conditions are present in subsets of IBD patients and include prolonged epithelial damage [43] , intestinal dysbiosis [41, 42 & ] or compromised antifungal immunity [3
,47] (Fig. 1) . We have recently shown that C. albicans and Candida tropicalis do not exacerbate the outcome of dextran sodium sulphate (DSS) intestinal inflammation in immune-competent mice [3 && ]. Significantly, immune-deficient hosts with an impaired antifungal immunity failed to control Candida spp. outgrowth and experience an exacerbated colitis [3 && ,47] . In mice deficient in the antifungal receptor Dectin-1 (Clec7a) opportunistic fungi can invade the intestinal mucosa and be detrimental during chemically induced colitis [47, 51] . We have recently shown that intestinal CX3CR1
þ MNPs express high amount of Dectin-1 and other C-type lectin receptors, can intake various fungal commensals and initiate antifungal adaptive immune responses via the Spleen tyrosine kinase (Syk) signaling pathway [3 && ]. Impaired CX3CR1 þ MNP function predisposed mice to intestinal disease caused by intestinal Candida spp. [3 && ]. Altogether these recent studies suggest that similar to commensal bacteria, gut mycobiota might be beneficial to host immunity and health, and can contribute to intestinal disease only under specific conditions. CX3CR1
þ MNPs appear as a key subset of phagocyte not only interacting with intestinal bacteria, but also with intestinal fungi. It remains to be investigated whether other cell types in the phagocyte network lining the intestines might also play a role in the 'transmission' of immunological signals generated upon fungal interactions with CX3CR1 þ MNPs.
Role of mononuclear phagocytes in antifungal antibody responses in inflammatory bowel disease Antibodies against S. cerevisiae's mannan (ASCA) are known to be increased in Crohn's disease patients even before the clinical diagnosis of Crohn's disease and are elevated in 20-25% of their first degree relatives [46, 52] . Significantly, their production is induced by both C. albicans and S. cerevisiae [46, 53] . However, the mechanisms behind ASCA generation are poorly understood. Crohn's disease patients with defects in the mannan-binding lectin that binds to component of the fungal cell wall, have increased level of circulating mannan and enhanced levels of circulating ASCA [54] . In Crohn's disease patients, a dysfunctional CX3CR1 variant is associated with the development of intestinal stenosis and ileocolonic involvement. This mutation has been previously associated with increased risk and worse outcome of human systemic candidiasis [57] and interferes with the fractalkine-mediated survival of blood monocytes [58] . Moreover, Crohn's disease patients carrying this mutation have reduced serum levels of ASCA IgG and present reduced IgG titers against a variety of fungal commensals [3 && ]. These findings suggest that in these individuals a reduced number of CX3CR1 þ MNPs results in impaired antifungal humoral responses. Whether antibody responses against fungi play any role in disease outcome or/and control of mycobiota, remains to be elucidated.
CONCLUSION
Intestinal resident macrophages are increasingly recognized as key cellular sensors that integrate signals from the luminal microbiota to regulate intestinal homeostasis. Recent evidences suggest that they actively promote an anti-inflammatory environment in the healthy gut and can shift to a proinflammatory state in response to deviations in the intestinal microbiota. It is crucial to better understand the cellular networks between intestinal resident macrophages, lymphocytes and gut epithelium in response to acute and chronic microbiota dysbiosis. Next steps should develop tools to precisely identify patients with compromised residentintestinal macrophages function and asses the clinical advantage of targeting both fungal and bacterial microbiota and immune dysfunctions within this subset of IBD patients.
